SPARC is a possible predictive marker for albumin-bound paclitaxel in non-small-cell lung cancer

OBJECTIVES: Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) produced good tumor response in cases with lung squamous cell carcinoma, one of the most difficult cancers to treat. Secreted protein acidic and rich in cysteine (SPARC) binds to albumin, suggesting that SPARC plays an important role...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Onco Targets Ther
Autors principals: Komiya, Kazutoshi, Nakamura, Tomomi, Nakashima, Chiho, Takahashi, Koichiro, Umeguchi, Hitomi, Watanabe, Naomi, Sato, Akemi, Takeda, Yuji, Kimura, Shinya, Sueoka-Aragane, Naoko
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2016
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5089830/
https://ncbi.nlm.nih.gov/pubmed/27822069
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S114492
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars